OVA Conjugated Nitrotyrosine (NT) Pan-species (General) Conjugated small molecules

3-Nitro-L-Tyrosine; 3-Nitrotyrosine

Add to Cart Distributors
Overview
Properties
  • SourceProtein Conjugation
  • Original Molecular Mass226.2Da
  • Buffer FormulationPBS, pH7.4.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • OVA Conjugated Nitrotyrosine (NT) Packages (Simulation)
  • OVA Conjugated Nitrotyrosine (NT) Packages (Simulation)
  • OVA Conjugated Nitrotyrosine (NT)
  • CPB863Ge21.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Formula

Usage

Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • 3-Nitrotyrosine, a biomarker for cardiomyocyte apoptosis induced by diabetic cardiomyopathy in a rat modelPubmed: 23970331
  • Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitisPubmed:24992835
  • Glycyrrhizic Acid Prevents Sepsis-Induced Acute Lung Injury and Mortality in RatsPubMed: 26385569
  • Protective effects of Telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuro-inflammation and amyloidogenesis: possible role of brain derived neurotrophic factor10.1139:cjpp-2017-0042
  • The cardiovascular phenotype of adult patients with phenylketonuriaPubmed: 31492166
  • The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice33303990

Recommend products